Skip to main content

Zhengye Biotechnology Holding Ltd

corporate_fare Company Profile

Zhengye Biotechnology Holding Ltd

ZYBT·NASDAQ·Life Sciences·CIK 0001975641

The company focuses on the research, development, manufacturing, and sales of veterinary vaccines, primarily for livestock. For over 20 years, the operating entity has been dedicated to improving animal health. It offers a variety of vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company's products are sold in 29 provincial regions throughout China and are exported to Vietnam, Pakistan, and Egypt. The company's revenues are influenced by its ability to develop high-demand products, expand into the household animal vaccines industry beyond livestock, grow its sales and distribution network, upgrade technological capabilities, and maintain product quality. The company generates revenue from three main categories: swine vaccines, poultry vaccines, and other vaccines.

Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for ZYBT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for ZYBT spans 6-K, 20-F.

Recent high-impact activity:

  • Zhengye H1 2026: Revenue Falls 18%, Going-Concern Doubt Disclosed
  • Zhengye Biotechnology Regains Nasdaq Compliance, Removing Delisting Risk
  • Zhengye Biotechnology Receives Nasdaq Delisting Warning for Sub-$1.00 Stock Price
  • Zhengye Biotechnology Reports 21-Cent Loss Per Share for 2025
  • Zhengye Biotechnology Reports Substantial FY2025 Net Loss, Revenue Decline, and Material Weakness in Internal Controls; Adopts Dual-Class Share Structure

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
¥116.36M CNY
Net Income
-¥69.78M CNY
Op. Cash Flow
¥13.33M CNY
Free Cash Flow
¥12.32M CNY
Gross Profit
¥23.87M CNY
Operating Income
-¥70.51M CNY
Cash & Equivalents
¥50.33M CNY
Total Debt
¥10.25M CNY
Debt / Equity
0.04×
Net Margin
-60.0%
Shares Outstanding
47.35M sh
Source: 20-F · filed 2026-04-28 · accession 0001213900-26-048584

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 31,167 shares in ZYBT as of the October 30, 2026 settlement, a 53.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 22.2% of ZYBT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)31,167 shares as of October 30, 2026
Change vs prior period▼ 53.9%
Days to cover1.00 at avg daily volume of 70,312
Daily short volume (FINRA facilities)22.2% of 5,495 shares on November 20, 2026
5-day average short volume32.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

ZYBT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with Z →
$1.5 +1.35% today
52-week range · as of 2026-11-12 $0.6155 – $8.01
Market cap
$70.14M
Volume
10.6K (0.1× avg)
3-mo avg 159.9K
Live data · 2026-11-22 05:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ZYBT - Latest Insights

ZYBT
Nov 12, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.50 info
Change: $0 (0%) info
Market Cap: $70.139M info
ZYBT
Aug 06, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.50 info
Change: -$0.680 (-31%) info
Market Cap: $70.139M info
ZYBT
Jun 04, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.830
Real-time Price: $1.50 info
Change: +$0.670 (+81%) info
Market Cap: $70.139M info
ZYBT
Apr 28, 2026, 4:55 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.9225
Real-time Price: $1.50 info
Change: +$0.5775 (+63%) info
Market Cap: $70.139M info
ZYBT
Apr 28, 2026, 4:31 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.9225
Real-time Price: $1.50 info
Change: +$0.5775 (+63%) info
Market Cap: $70.139M info
ZYBT
Mar 24, 2026, 7:16 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.820
Real-time Price: $1.50 info
Change: +$0.680 (+83%) info
Market Cap: $70.139M info
ZYBT
Feb 27, 2026, 7:11 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.800
Real-time Price: $1.50 info
Change: +$0.700 (+87%) info
Market Cap: $70.139M info
ZYBT
Feb 23, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8592
Real-time Price: $1.50 info
Change: +$0.6408 (+75%) info
Market Cap: $70.139M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets